{"filing":{"accession_number":"0001156375-26-000042","cik":"0001156375","ticker":"CME","company_name":"CME GROUP INC.","form":"8-K","filing_date":"2026-07-22","report_date":null,"primary_document":"cme-20260722.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1156375/000115637526000042/cme-20260722.htm"},"events":[{"id":19334,"run_id":17395,"accession_number":"0001156375-26-000042","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"CME Group disclosed its Q2 2026 financial results via press release dated July 22, 2026, reporting revenue of $1.7 billion, operating income of $1.1 billion, net income of $1.0 billion, and diluted EPS of $2.88. The filing explicitly states that Exhibit 99.1 is \"a copy of a press release of CME Group Inc. dated July 22, 2026, reporting CME Group Inc.'s financial results for the quarter ended June 30, 2026,\" which is the classic structure of an earnings release disclosure under Item 2.02.","company_name":"CME GROUP INC.","ticker":"CME","filing_date":"2026-07-22","form":"8-K","submitted_at":null,"items":[{"id":18396,"accession_number":"0001156375-26-000042","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"CME Group disclosed its Q2 2026 financial results via press release dated July 22, 2026, reporting revenue of $1.7 billion, operating income of $1.1 billion, net income of $1.0 billion, and diluted EPS of $2.88. The filing explicitly states that Exhibit 99.1 is \"a copy of a press release of CME Group Inc. dated July 22, 2026, reporting CME Group Inc.'s financial results for the quarter ended June 30, 2026,\" which is the classic structure of an earnings release disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T11:16:37.808790+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18396,"accession_number":"0001156375-26-000042","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"CME Group disclosed its Q2 2026 financial results via press release dated July 22, 2026, reporting revenue of $1.7 billion, operating income of $1.1 billion, net income of $1.0 billion, and diluted EPS of $2.88. The filing explicitly states that Exhibit 99.1 is \"a copy of a press release of CME Group Inc. dated July 22, 2026, reporting CME Group Inc.'s financial results for the quarter ended June 30, 2026,\" which is the classic structure of an earnings release disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T11:16:37.808790+00:00","company_name":"CME GROUP INC.","ticker":"CME","filing_date":"2026-07-22"}]}
